CLARIVATE PLC

Clarivate’s cash‑tender offer bought back 11.3 % of its $825 M senior notes, prioritizing liquidity over shareholder payouts and sparking debate on its future value.

Clarivate PLC announces a debt‑purchase offer and Q3 2026 earnings release, revealing key terms, market data, and investor insights for 2026.

Clarivate expands agentic AI across Cortellis, speeding drug‑discovery, safety assessment, and competitive intelligence for life‑sciences R&D.

Clarivate’s new IPOne platform blends AI agents with proprietary IP data, enabling smarter discovery, clearance, and monitoring for law firms and corporate IP teams.

Clarivate PLC has announced a leadership change, appointing Maroun S. Mourad as President of its Intellectual Property segment, and reported Q2 2025 results with a decline in revenue but reaffirmed 2025 outlook and confidence in its financial strate…

Clarivate PLC reported a 4.5% decrease in total revenues for Q1 2025, but still exceeded earnings and revenue estimates, reaffirming its 2025 outlook and announcing a $50 million share repurchase.

Clarivate PLC reported a mixed bag of first quarter 2025 results, with a decline in total revenues but a 0.3% increase in organic revenue growth, driven by a 0.6% rise in organic recurring revenues.

Clarivate PLC reported a net loss of $103.9 million in Q1 2025, but reaffirmed its outlook and took strategic steps to strengthen its market position, including a $50 million share repurchase.